Nexalin Technology EBIT Margin 2021-2024 | NXL
Nexalin Technology EBIT Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBIT | EBIT Margin |
2024-12-31 | $0.00B | $-0.01B | 0.00% |
2024-09-30 | $0.00B | $-0.01B | 0.00% |
2024-06-30 | $0.00B | $-0.01B | 0.00% |
2024-03-31 | $0.00B | $-0.01B | 0.00% |
2023-12-31 | $0.00B | $-0.01B | 0.00% |
2023-09-30 | $0.00B | $-0.01B | 0.00% |
2023-06-30 | $0.00B | $0.00B | -300.00% |
2023-03-31 | $0.00B | $0.00B | -200.00% |
2022-12-31 | $0.00B | $0.00B | -100.00% |
2022-06-30 | $0.00B | $0.00B | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Business Services | Technology Services | $0.024B | $0.000B |
Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas. |